Current treatment of oral candidiasis: A literature review

Journal of Clinical and Experimental Dentistry

Volumn 6, Issue 5, 2014, Pages e576-e582

  Garcia Cuesta, Carla ^a   Sarrion Pérez, Maria Gracia ^a   Bagán, Jose V ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Candidiasis; Fluconazole; Miconazole; Nystatin; Treatment

Indexed keywords

EID: 84917729011     PISSN: None     EISSN: 19895488     Source Type: Journal    
DOI: 10.4317/jced.51798     Document Type: Article

References (34)

1. Arendrup MC, Fuursted K, Gahrn-Hansen B, Jensen IM, Knudsen JD, Lundgren B, et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol. 2005;43:4434-40.
2. Rodloff C, Koch D, Schaumann R. Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res. 2011;16:187-95.
3. Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:488-95.
4. Williams DW, Kuriyama T, Silva S, Malic S, Lewis MA. Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000. 2011;55:250-65.
5. Coronado-Castellote L, Jiménez-Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J Clin Exp Dent. 2013;5:e279-86.
6. Byadarahally Raju S, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRN Dent. 2011;2011:487921.
7. Aguirre Urizar JM. Oral Candidiasis. Rev Iberoam Micol. 2002;19:17-21.
8. Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011;28:3.
9. Martínez-Beneyto Y, López-Jornet P, Velandrino-Nicolás A, Jornet-García V. Use of antifungal agents for oral candidiasis: results of a national survey. Int J Dent Hyg. 2010;8:47-52.
10. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78:455-9.
11. Manfredi M, Polonelli L, Aguirre-Urizar JM, Carrozzo M, McCullough MJ. Urban legends series: oral candidosis. Oral Dis. 2013;19:245-61.
12. Koray M, Ak G, Kurklu E, Issever H, Tanyeri H, Kulekci G, et al. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. Oral Dis. 2005;11:309-13.
13. Cross LJ, Williams DW, Sweeney CP, Jackson MS, Lewis MA, Bagg J. Evaluation of the recurrence of denture stomatitis and Candida colonization in a small group of patients who received itraconazole. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:351-8.
14. Goins RA, Ascher D, Waecker N, Arnold J, Moorefield E. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. Pediatr Infect Dis J. 2002;21:1165-7.
15. Epstein JB, Gorsky M, Caldwell J. Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:671-5.
16. Lefebvre JL, Domenge C; Study Group of Mucositis. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. Oral Oncol. 2002;38:337-42.
17. Sholapurkar AA, Pai KM, Rao S. Comparison of efficacy of fluconazole mouthrinse and clotrimazole mouthpaint in the treatment of oral candidiasis. Aust Dent J. 2009;54:341-6.
18. Taillandier J, Esnault Y, Alemanni M. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group. Age Ageing. 2000;29:117-23.
19. Isham N, Ghannoum MA. Antifungal activity of miconazole against recent Candida strains. Mycoses. 2010;53:434-7.
20. Pemberton MN, Oliver RJ, Theaker ED. Miconazole oral gel and drug interactions. Br Dent J. 2004;196:529-31.
21. Miki A, Ohtani H, Sawada Y. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model. J Clin Pharm Ther. 2011;36:642-50.
22. Collins CD, Cookinham S, Smith J. Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability. Patient Prefer Adherence. 2011;5:369-74.
23. Vazquez JA, Sobel JD. Miconazole mucoadhesive tablets: a novel delivery system. Clin Infect Dis. 2012;54:1480-4.
24. Czerninski R, Sivan S, Steinberg D, Gati I, Kagan L, Friedman M. A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis. Clin Oral Investig. 2010;14:71-8.
25. Oji C, Chukwuneke F. Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. Oral Maxillofac Surg. 2008;12:67-71.
26. Bensadoun RJ, Daoud J, El Gueddari B, Bastit L, Gourmet R, Rosikon A, et al. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer. 2008;112:204-11.
27. Koks CH, Crommentuyn KM, Mathôt RA, Mulder JW, Meenhorst PL, Beijnen JH. Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals. Pharmacol Res. 2002;46:89-94.
28. Lyon JP, de Resende MA. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:632-8.
29. Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, et al.; EORTC Invasive Fungal Infections Group. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. Eur J Cancer. 2004;40:1314-9.
30. Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral Candida to seven antifungal agents.Oral Microbiol Immunol. 2005;20:349-53.
31. Brito GN, Inocêncio AC, Querido SM, Jorge AO, Koga-Ito CY. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. Braz Oral Res. 2011;25:28-33.
32. Ally R, Schürmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, et al. Esophageal Candidiasis Study Group. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis. 2001;33:1447-54.
33. Khozeimeh F, Shahtalebi MA, Noori M, Savabi O. Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. J Contemp Dent Pract. 2010;11:017-24.
34. Van Roey J, Haxaire M, Kamya M, Lwanga I, Katabira E. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr. 2004;35:144-50.